Una candidatura completa in un minuto
Curriculum e lettera di presentazione personalizzati, pronti da inviare.
Quantum Health, Inc. seeks a Pharmacy Strategy and Market Intelligence Lead for a remote 4‑month contract. The role drives strategy from research to executive decisions within 90 days, shaping TCOC reductions and 2027/2028 planning with strong data-backed options.
Ideal candidates have deep pharmacy market knowledge, competitive intelligence experience, and the ability to size options using claims data and cost drivers. Excellent communication to C-suite is required.
***This is a 4 month "Remote" contract role***
This role is remote
This role is for 4 months
This role leads our commercial pharmacy strategy from research to executive decisions in 90 days. It combines two areas of focus: building the necessary decision insights and understanding what carriers, PBMs, navigation companies and health systems are doing and what actually works.
The Lead will turn landscape research, competitor intelligence and our claims data into frameworks and options the executive team can decide on. The outcome by day 90 are executive team decisions that move pharmacy total cost of care (TCOC) in 2027 and place strong bets for 2028 with alignment on likely savings target and investment.
This role requires a lead who understands the pharmacy market, has deep knowledge of the competitive landscape, and able to size the options with our data to drive the executive team to decisions.
Our pharmacy strategy will need to drive the following decisions based on ability to impact TCOC in the time frames required for our book of business:
Horizon Focus Examples
0–12 months impact Optimization of existing solutions Net new solutions Biosimilar-first formulary, infusion site of care, specialty high-cost drug clinical criteria and lifestyle support, adherence outreach
12–24 months impact Optimization of existing solutions and partners Net new solutions Transparent pass-through PBM terms; integrated medical and pharmacy specialty management
24–36 months impact Optimization of existing solutions and partners Net new solutions Gene therapy and oncology drug financing, pipeline watch list
By Day 30 Fact base reviewed; pharmacy spend at BOB and client split into price, use and mix; current programs and their results; PBM contract terms reviewed where available
By Day 60 Evidence grid and competitor heat map complete; expert calls done; external solution landscape complete; options shortlisted
By Day 90 Executive team makes key decisions to inform 2027 and 2028 roadmap tied to specific TCOC reductions, growth and retention goals.
Reports to Chief Medical Officer
Works closely with Pharmacy economics lead, clinical pharmacist, pharmacy data analyst, actuary, finance partner, client and consultant relations lead, legal
Executive audience CEO and executive team
Location Remote